Things like this are why we don't run general screening for rare diseases.
The risk from screening, and the risks from further diagnosis and accidental treating of false positives can be much higher than the disease itself as long as it is rare enough.
The risk from screening, and the risks from further diagnosis and accidental treating of false positives can be much higher than the disease itself as long as it is rare enough.